Literature DB >> 19886821

Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell.

Yves Lepelletier1, Séverine Lecourt, Amédée Renand, Bertrand Arnulf, Valérie Vanneaux, Jean-Paul Fermand, Philippe Menasché, Thomas Domet, Jean-Pierre Marolleau, Olivier Hermine, Jérôme Larghero.   

Abstract

In human physiology and animal models, bone marrow mesenchymal stem cells (MSCs) exert an immunosuppressive role in both in vitro and in vivo experiments. However, cellular and molecular mechanisms involved in this process are not clear and remain largely elusive. Several studies have suggested the implication of cell-cell contacts or soluble factors including transforming growth factor-b1 (TGF-b1), interleukin-10 (IL-10), indoleamine 2,3-dioxygenase (IDO), or human leukocyte antigen-G (HLA-G). Here, we show that both Galectin-1 and Semaphorin-3A (Sema-3A), 2 soluble factors capable to inhibit T-cell proliferation through neuropilin-1 (NP-1) binding, are highly expressed by MSCs and may account for their known suppressive activities. Furthermore, MSCs suppressive functions are completely reverted by soluble recombinant NP-1, the main receptor of both Galectin-1 and Sema-3A. Similar results were obtained by using blocking antibodies against Galectin-1 or Sema-3A. Taken together, these results demonstrate the critical role of Galectin-1 and Sema-3A in MSCs functions and may open new perspectives in the understanding and treatment of various immune and neoplastic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19886821     DOI: 10.1089/scd.2009.0212

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  43 in total

1.  Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis.

Authors:  Hui Gao; Xiao-Xu Ma; Qian Guo; Lin-Feng Xie; Yu-Chao Zhong; Xue-Wu Zhang
Journal:  Clin Rheumatol       Date:  2018-04-14       Impact factor: 2.980

Review 2.  The bone marrow stroma in hematological neoplasms--a guilty bystander.

Authors:  Claudio Tripodo; Sabina Sangaletti; Pier P Piccaluga; Sonam Prakash; Giovanni Franco; Ivan Borrello; Attilio Orazi; Mario P Colombo; Stefano A Pileri
Journal:  Nat Rev Clin Oncol       Date:  2011-03-29       Impact factor: 66.675

Review 3.  Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

Authors:  Marina Gazdic; Vladislav Volarevic; Nebojsa Arsenijevic; Miodrag Stojkovic
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 4.  Current understanding of the immunosuppressive properties of mesenchymal stromal cells.

Authors:  Ligia Lins de Castro; Miquéias Lopes-Pacheco; Daniel Jay Weiss; Fernanda Ferreira Cruz; Patricia Rieken Macêdo Rocco
Journal:  J Mol Med (Berl)       Date:  2019-03-22       Impact factor: 4.599

Review 5.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

6.  A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression.

Authors:  Sabino Ciavarella; Anna Caselli; Antonella Valentina Tamma; Annalisa Savonarola; Giuseppe Loverro; Roberto Paganelli; Marco Tucci; Franco Silvestris
Journal:  Stem Cells Dev       Date:  2015-03-11       Impact factor: 3.272

Review 7.  Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis.

Authors:  Peter J Darlington; Marie-Noëlle Boivin; Amit Bar-Or
Journal:  Expert Rev Neurother       Date:  2011-09       Impact factor: 4.618

8.  Semaphorin 3A induces mesenchymal-stem-like properties in human periodontal ligament cells.

Authors:  Naohisa Wada; Hidefumi Maeda; Daigaku Hasegawa; Stan Gronthos; Peter Mark Bartold; Danijela Menicanin; Shinsuke Fujii; Shinichiro Yoshida; Atsushi Tomokiyo; Satoshi Monnouchi; Akifumi Akamine
Journal:  Stem Cells Dev       Date:  2014-02-10       Impact factor: 3.272

Review 9.  Lasers, stem cells, and COPD.

Authors:  Feng Lin; Steven F Josephs; Doru T Alexandrescu; Famela Ramos; Vladimir Bogin; Vincent Gammill; Constantin A Dasanu; Rosalia De Necochea-Campion; Amit N Patel; Ewa Carrier; David R Koos
Journal:  J Transl Med       Date:  2010-02-16       Impact factor: 5.531

Review 10.  Semaphorins: their dual role in regulating immune-mediated diseases.

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.